Ruoyao Zou

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer

Ruoyao Zou, Qidi Jiang, Tianqiang Jin et al. · Frontiers in Immunology · 2022 · 61 citations · Full text

Medicine, Immunology, Oncology +17

RETRACTED ARTICLE: Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation

Hongda Ding, Junpeng Liu, Ruoyao Zou et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +17

MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer

Haoya Xu, Ruoyao Zou, Feifei Li et al. · Cancer Medicine · 2021 · 49 citations · Full text

Medicine, Molecular Biology, Oncology +17

Increased Expression of <i>UBE2T</i> Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of <i>UBE2s</i> , Clinical Samples, and the GEO Database

Ruoyao Zou, Haoya Xu, Feifei Li et al. · DNA and Cell Biology · 2020 · 30 citations

Medicine, Molecular Biology, Oncology +17

&lt;p&gt;Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation&lt;/p&gt;

Ruoyao Zou, Mingjun Zheng, Mingzi Tan et al. · Cancer Management and Research · 2020 · 26 citations · Full text

Medicine, Bioinformatics, Oncology +17